Upcoming Events
Log In
Pricing
Free Trial

PET-CT in Abdominal Pathologies, Sikandar Shaikh, DMRD, DNB, MNAMS, FICR, EDiR, 05/12/22

HIDE
PrevNext

0:01

Hello and welcome to Noon Conference hosted by MRI Online. Noon Conference

0:06

was created when the pandemic hit as a way to connect the global

0:09

radiology community through free live educational conferences that are accessible

0:13

for all. It has become an amazing weekly opportunity to learn alongside

0:17

radiologists from around the world, and we encourage you to ask questions

0:20

and share ideas to help the community learn and grow.

0:23

You can access the recording of today's conference and previous Noon Conferences

0:27

by creating a free MRI Online account. The link will be provided in

0:30

the chat box. You can also sign up for a free trial of

0:33

MRI Online premium membership to get access to hundreds of case based micro

0:38

learning courses across all key radiology sub specialties. Learn more at

0:42

mrionline.com. Today we're honored to welcome Dr. Sikandar for a lecture

0:47

on PET CT and abdominal pathologies. Dr. Sikandar is president of the ISMRM

0:55

India chapter, Indian ambassador of the European Society of Hybrid, Molecular

1:00

and Translational Imaging, and associate editor of the International Journal

1:04

of MRI. At the end of the lecture, join Dr. Sikandar in a

1:08

Q&A session where he will address questions you may have on today's topic.

1:12

Please use the Q&A chat feature to submit your questions, and we will

1:16

get to as many as we can before our time is up. Closed

1:19

captioning and subtitles and a live transcript is now available for this

1:22

meeting. You can turn on captioning using the closed captioning button at

1:26

the bottom of your Zoom screen. You can also view the full transcript

1:30

by selecting the arrow next to the CC Live Transcript button and clicking

1:34

View Full Transcript. You can disable either at any time by navigating to

1:38

the same button and clicking Hide Subtitle or Close Full Transcript.

1:43

Please note this is a new feature, so it may not be 100%

1:46

accurate. But that being said, we are ready to begin today's lecture.

1:50

Dr. Sikandar, please take it from here. Thank you for a nice introduction,

1:57

and I welcome all the attendees pan world. Good morning, good afternoon,

2:01

and good evening to all of you. Now moving on. My topic today

2:09

is PET CT in abdominal pathologies. But before that, I just want to

2:13

give you a very short and brief overview of what exactly the molecular imaging.

2:18

We know there are different presets and there are different components,

2:22

different modalities which are involved in this molecular imaging. And the

2:27

commonest ones are magnetic resonance that is MR, optical imaging, SPECT,

2:32

PET probes and imaging of molecular interaction, nano imaging, stem cell

2:37

imaging, genetic imaging, and optical imaging variants like you have bioluminescence,

2:43

fluorescence and other things. Now coming to the molecular imaging, it is

2:48

early 21st century, it is a discipline of intersection of molecular biology

2:54

and in vivo imaging. So it is a visualization of the cellular functions,

2:59

which is follow up of the molecular processes without disturbing them.

3:03

So the diagnosis of diseases like cancer, neurological and cardiovascular

3:08

pathologies can be easily diagnosed. And this is how the evolution of the

3:13

molecular and functional imaging has given a new direction to the human

3:18

genome. We all know the molecular imaging is also a part of traditional

3:24

imaging, because a lot of probes which are known as biomarkers were used.

3:29

And this image particularly targets all the various pathways which are involved

3:34

in this molecular imaging. So what is the role of biomarkers? They interact

3:39

chemically in their surroundings, they alter the image, they can do molecular

3:44

changes. But most important within the areas of interest.

3:49

So here, focusing the area of interest, the molecular imaging can be targeted

3:54

and used as a diagnostic tool, and in future, used as a therapeutic tool.

3:59

So that is where the diagnostics will be coming in picture.

4:04

Now we all know the different modalities. Now coming to PET. Just very

4:09

brief overview of PET. PET is a positron emission tomography and computed

4:13

tomography. It is a combination of functional as well as anatomical imaging.

4:18

And that's the reason it is known as metabolic imaging technique using the

4:23

radio labeled analogs like glucose, as glucose is one of the important metabolic

4:29

agent or the active agent which is being used by the normal tissues,

4:36

and this is significantly increased in the malignancies. And coming to CT,

4:41

we all know it is a tomographic imaging technique which uses an X ray beam

4:44

to produce anatomical images. So this anatomical information is needed to

4:49

detect, determine the location and extent of the malignancies.

4:55

So it is a hybrid modality. It is a hybrid scanner with an

4:59

integrated devices containing both CT as well as PET in a single patient

5:05

table and capable of doing both CT or PET or both at a time. Usually, PET

5:11

CT is used for the PET, but in some scenarios we can do

5:14

CT individually. So that is also an individual application of PET individually,

5:19

but PET usually is not being done now with the advent of the hybrid imaging.

5:25

So it is a fusion of the process of aligning these both images

5:28

leading to combined imaging displays, leading to various analysis. So this

5:34

analysis is based on the combination of the images and displaying the images,

5:39

and these fused images are displayed in various color coding that is

5:44

available by different vendors. And CT, we all know it is being used

5:48

by the grayscale. Now coming to the important aspect before going directly

5:54

to the cases. So we have the scintillators. So what is the role of

5:57

scintillators? They are the basic components, like we have detectors on

6:02

the PET CT. So scintillators are comprised of the various components,

6:07

like you have thallium, which are activated with sodium iodide, bismuth

6:11

germanate, gadolinium oxyorthosilicate, and lutetium oxyorthosilicate that

6:17

is light output. So among this, the most widely commonly used scintillator

6:23

is lutetium oxyorthosilicate, that is LSO crystal, and these are having

6:27

13 by 13 LSO block detectors. Now coming to the positron emitters.

6:33

So what are the emitters actually? So these are positron emitters. You have

6:38

radioisotopes and you have half life. So these are the emitters which are

6:42

based on the radioactivity. So radioactivity means you have to have the

6:46

radioisotope. What is a radioisotope? So it is a natural or artificial form

6:53

of an element which is known as radioisotope. But here in PET, most

6:57

of them, they are prepared artificially in a cycle.

Report

Faculty

Sikandar Shaikh, DMRD

PET-CT IN ONCOLOGY

Yashoda Hospitals, Hyderabad, India

Tags

PET/CT FDG

PET

Oncologic Imaging

Nuclear Medicine

© 2024 Medality. All Rights Reserved.

Contact UsTerms of UsePrivacy Policy